TY - JOUR
T1 - Epidemiology of cardiovascular disease in Europe
AU - Townsend, Nick
AU - Kazakiewicz, Denis
AU - Lucy Wright, F.
AU - Timmis, Adam
AU - Huculeci, Radu
AU - Torbica, Aleksandra
AU - Gale, Chris P.
AU - Achenbach, Stephan
AU - Weidinger, Franz
AU - Vardas, Panos
N1 - Publisher Copyright:
© 2021, Springer Nature Limited.
PY - 2021/9/8
Y1 - 2021/9/8
N2 - This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. Deaths from CVD in those aged <70 years, commonly referred to as premature, are a particular concern, with >60 million potential years of life lost to CVD in Europe annually. Although more women than men die from CVD, age-standardized rates of both morbidity and death are higher in men, and these differences in rates are greatest in individuals aged <70 years. Large inequalities in all measures of morbidity, treatment and mortality can be found between countries across the continent and must be a focus for improving health. Large differences also exist in the data available between countries. The development and implementation of evidence-based preventive and treatment approaches must be supported in all countries by consistent surveillance and monitoring, such that we can quantify the health burden of CVD as well as target interventions and provide impetus for action across Europe.
AB - This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. Deaths from CVD in those aged <70 years, commonly referred to as premature, are a particular concern, with >60 million potential years of life lost to CVD in Europe annually. Although more women than men die from CVD, age-standardized rates of both morbidity and death are higher in men, and these differences in rates are greatest in individuals aged <70 years. Large inequalities in all measures of morbidity, treatment and mortality can be found between countries across the continent and must be a focus for improving health. Large differences also exist in the data available between countries. The development and implementation of evidence-based preventive and treatment approaches must be supported in all countries by consistent surveillance and monitoring, such that we can quantify the health burden of CVD as well as target interventions and provide impetus for action across Europe.
UR - http://www.scopus.com/inward/record.url?scp=85114648966&partnerID=8YFLogxK
U2 - 10.1038/s41569-021-00607-3
DO - 10.1038/s41569-021-00607-3
M3 - Review article (Academic Journal)
C2 - 34497402
AN - SCOPUS:85114648966
SN - 1759-5002
VL - 19
SP - 133
EP - 143
JO - Nature Reviews Cardiology
JF - Nature Reviews Cardiology
IS - 2
ER -